Viewing Study NCT05425732


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-01-07 @ 1:28 AM
Study NCT ID: NCT05425732
Status: COMPLETED
Last Update Posted: 2024-10-26
First Post: 2022-06-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-07-13
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-18
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-18
Completion Date Type: ACTUAL
First Submit Date: 2022-06-15
First Submit QC Date: None
Study First Post Date: 2022-06-21
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-05-10
Results First Submit QC Date: None
Results First Post Date: 2024-06-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-15
Last Update Post Date: 2024-10-26
Last Update Post Date Type: ACTUAL